Previous studies have shown genetic variants in the LIPC affect the activity of LIPC and contribute to the risk of several diseases, including coronary artery disease (CAD), type 2 diabetes, metabolic syndrome and HL deficiency. The gene discussed is LIPC; the disease is coronary artery disorder.